UNII K679OBS311

CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM

Unique Ingredient Identifier K679OBS311 is listed as a unspecified ingredient
UniiK679OBS311
Preferred Substance NameCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM
Rn9004-32-4
NcitC83596
Rxcui491498
Unii TypeUNSPECIFIED INGREDIENT
RN9004-32-4
NCITC83596
RXCUI491498

Alternate Names

Dosage Forms

UNII K679OBS311 CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM is commonly included in medications in the following forms.

RouteDosage FormPotency
INTRA-ARTICULARINJECTION0.75 %
INTRAMUSCULARINJECTION0.75 %
ORALTABLET, DELAYED RELEASE36 mg
ORALTABLET, EXTENDED RELEASE40 mg
ORALTABLET105 mg
DENTALGEL0.4 %
DENTALPASTE174 MG
ENTERALSUSPENSION29.2 MG/ML
IM - IVINJECTION NA
INTRA-ARTICULARINJECTABLE0.75 %
INTRA-ARTICULARINJECTION7.5 MG/1ML
INTRA-ARTICULARINJECTION0.76 %
INTRA-ARTICULARINJECTION, SUSPENSION, EXTENDED RELEASE25 MG
INTRA-ARTICULARINJECTION, SUSTAINED ACTION NA
INTRABURSALINJECTION0.76 %
INTRADERMALINJECTION NA
INTRADERMALINJECTION, SUSTAINED ACTION NA
INTRALESIONALINJECTION NA
INTRALESIONALINJECTION, SUSTAINED ACTION NA
INTRAMUSCULARINJECTABLE15 mg
INTRAMUSCULARINJECTABLE0.75 %W/V
INTRAMUSCULARINJECTION25 mg
INTRAMUSCULARINJECTION3 %
INTRAMUSCULARINJECTION, MICROSPHERES1 %
INTRAMUSCULARINJECTION, SUSTAINED ACTION NA
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED3 %
INTRAMUSCULARPOWDER, FOR INJECTION SUSPENSION0.7 %W/V
INTRASYNOVIALINJECTION0.1 %
INTRASYNOVIALINJECTION, SUSTAINED ACTION NA
INTRATRACHEALSUSPENSION NA
INTRAVITREALSUSPENSION, INJECTION0.5 %
NASALSPRAY, METERED0.15 %
OPHTHALMICSOLUTION0.5 %
OPHTHALMICSOLUTION, DROPS0.5 %
ORALCAPSULE160 MG
ORALCAPSULE, DELAYED ACTION, COATED, HARD GELATIN4 MG
ORALCAPSULE, ENTERIC COATED PELLETS4.2 MG
ORALCAPSULE, HARD GELATIN NA
ORALCAPSULE, SUSTAINED ACTION0.47 MG
ORALDROPS12.85 MG/2.5ML
ORALGRANULE25.7 MG
ORALGRANULE, FOR SUSPENSION NA
ORALPOWDER, FOR ORAL SOLUTION4.2 MG
ORALPOWDER, FOR SOLUTION2.63 MG/1ML
ORALPOWDER, FOR SUSPENSION1 %
ORALSOLUTION35 MG
ORALSUSPENSION2000 MG/5ML
ORALSUSPENSION, DROPS2.5 MG/2.5ML
ORALSUSPENSION, SYRUP, SUSTAINED ACTION0.02 %
ORALSYRUP50 MG/5ML
ORALTABLET48 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE24.75 MG
ORALTABLET, COATED3.2 MG
ORALTABLET, CONTROLLED RELEASE0.04 mg
ORALTABLET, DELAYED ACTION50 MG
ORALTABLET, EXTENDED RELEASE233.3 MG
ORALTABLET, FILM COATED50 MG
ORALTABLET, FILM COATED, EXTENDED RELEASE50.02 MG
ORALTABLET, SUSTAINED ACTION155 MG
SOFT TISSUEINJECTION0.5 %
SUBCUTANEOUSIMPLANT16 MG
SUBCUTANEOUSINJECTION NA
TOPICALFILM, CONTROLLED RELEASE700 MG
TOPICALJELLY NA
TOPICALLOTION NA
TOPICALPASTE NA
TOPICALPASTE, DENTIFRICE NA
TOPICALPATCH210 MG
TOPICALPATCH, CONTROLLED RELEASE NA
TOPICALSOLUTION0.5 %W/W
VAGINALEMULSION, AEROSOL FOAM0.2 %

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.